IL-2-controlled expression of multiple T cell trafficking genes and Th2 cytokines in the regulatory T cell-deficient scurfy mice: Implication to multiorgan inflammation and control of skin and lung inflammation

Journal of Immunology

Volumn 186, Issue 2, 2011, Pages 1268-1278

  Sharma, Rahul ^a,b   Sharma, Poonam R ^a   Kim, Young Chul ^b   Leitinger, Norbert ^a   Lee, Jae K ^b   Fu, Shu Man ^a,b   Ju, Shyr Te ^a,b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CELL EXPANSION; CELLULAR IMMUNODEFICIENCY; CHEMOTAXIS; COLITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE CONTROL; GENE EXPRESSION; GENE MUTATION; GENETIC CODE; HEPATITIS; HISTOPATHOLOGY; LYMPHOCYTE MIGRATION; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PANCREATITIS; PNEUMONIA; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SALIVARY GLAND DISEASE; SKIN INFLAMMATION; TH2 CELL;

ANIMALS; CELL MOVEMENT; CYTOKINES; GENE EXPRESSION REGULATION; INFLAMMATION; INTERLEUKIN-2; LUNG; LYMPHOPENIA; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MULTIPLE ORGAN FAILURE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SKIN; T-LYMPHOCYTES, REGULATORY; TH2 CELLS;

EID: 79251554090     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1002677     Document Type: Article

References (70)

1. Morgan, D. A., F. W. Ruscetti, and R. Gallo. 1976. Selective in vitro growth of T lymphocytes from normal human bone marrows. Science 193: 1007-1008.
2. Dooms, H., and A. K. Abbas. 2010. Revisiting the role of IL-2 in autoimmunity. Eur. J. Immunol. 40: 1538-1540.
3. Fontenot, J. D., J. P. Rasmussen, M. A. Gavin, and A. Y. Rudensky. 2005. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat. Immunol. 6: 1142-1151.
4. + T regulatory cell-mediated suppression. Immunity 30: 636-645.
5. Sakaguchi, S., K. Wing, Y. Onishi, P. Prieto-Martin, and T. Yamaguchi. 2009. Regulatory T cells: how do they suppress immune responses? Int. Immunol. 21: 1105-1111.
6. Kim, J. M., J. P. Rasmussen, and A. Y. Rudensky. 2007. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat. Immunol. 8: 191-197.
7. + regulatory T cells. J. Immunol. 178: 280-290.
8. Zheng, L., R. Sharma, F. Gaskin, S. M. Fu, and S. T. Ju. 2007. A novel role of IL-2 in organ-specific autoimmune inflammation beyond regulatory T cell checkpoint: both IL-2 knockout and Fas mutation prolong lifespan of Scurfy mice but by different mechanisms. J. Immunol. 179: 8035-8041.
9. Sharma, R., S. S. Sung, S. M. Fu, and S. T. Ju. 2009. Regulation of multi-organ inflammation in the regulatory T cell-deficient scurfy mice. J. Biomed. Sci. 16: 20.
10. Sharma, R., and S. T. Ju. 2010. Genetic control of the inflammatory T-cell response in regulatory T-cell deficient scurfy mice. Clin. Immunol. 136: 162-169.
11. Lin, W., N. Truong, W. J. Grossman, D. Haribhai, C. B. Williams, J. Wang, M. G. Martín, and T. A. Chatila. 2005. Allergic dysregulation and hyper-immunoglobulinemia E in Foxp3 mutant mice. J. Allergy Clin. Immunol. 116: 1106-1115.
12. + T cells in Scurfy mice that display both CD103-dependent and independent inflammation. J. Immunol. 183: 1065-1073.
13. Katz, J. D., B. Wang, K. Haskins, C. Benoist, and D. Mathis. 1993. Following a diabetogenic T cell from genesis through pathogenesis. Cell 74: 1089-1100.
14. Rosloniec, E. F., D. D. Brand, L. K. Myers, Y. Esaki, K. B. Whittington, D. M. Zaller, A. Woods, J. M. Stuart, and A. H. Kang. 1998. Induction of autoimmune arthritis in HLA-DR4 (DRB1*0401) transgenic mice by immunization with human and bovine type II collagen. J. Immunol. 160: 2573-2578.
15. Goverman, J., A. Woods, L. Larson, L. P. Weiner, L. Hood, and D. M. Zaller. 1993. Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity. Cell 72: 551-560.
16. Lafaille, J. J., K. Nagashima, M. Katsuki, and S. Tonegawa. 1994. High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient antimyelin basic protein T cell receptor transgenic mice. Cell 78: 399-408.
17. Huter, E. N., K. Natarajan, T. R. Torgerson, D. D. Glass, and E. M. Shevach. 2010. Autoantibodies in Scurfy mice and IPEX patients recognize keratin 14. J. Invest. Dermatol. 130: 1391-1399.
18. Zhang, W., R. Sharma, S. T. Ju, X. S. He, Y. Tao, K. Tsuneyama, Z. Tian, Z. X. Lian, S. M. Fu, and M. E. Gershwin. 2009. Deficiency in regulatory T cells results in development of antimitochondrial antibodies and autoimmune cholangitis. Hepatology 49: 545-552.
19. Sharma, R., U. S. Deshmukh, L. Zheng, S. M. Fu, and S. T. Ju. 2009. X-linked Foxp3 (Scurfy) mutation dominantly inhibits submandibular gland development and inflammation respectively through adaptive and innate immune mechanisms. J. Immunol. 183: 3212-3218.
20. Lee, H. H., C. M. Hoeman, J. C. Hardaway, F. B. Guloglu, J. S. Ellis, R. Jain, R. Divekar, D. M. Tartar, C. L. Haymaker, and H. Zaghouani. 2008. Delayed maturation of an IL-12-producing dendritic cell subset explains the early Th2 bias in neonatal immunity. J. Exp. Med. 205: 2269-2280.
21. Jain, N., J. Thatte, T. Braciale, K. Ley, M. O'Connell, and J. K. Lee. 2003. Local-pooled-error test for identifying differentially expressed genes with a small number of replicated microarrays. Bioinformatics 19: 1945-1951.
22. Tusher, V. G., R. Tibshirani, and G. Chu. 2001. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. USA 98: 5116-5121.
23. Pfaffl, M. W. 2001. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29: e45.
24. Homeister, J. W., A. D. Thall, B. Petryniak, P. Malý, C. E. Rogers, P. L. Smith, R. J. Kelly, K. M. Gersten, S. W. Askari, G. Cheng, et al. 2001. The α(1,3) fucosyltransferases FucT-IV and FucT-VII exert collaborative control over selectin-dependent leukocyte recruitment and lymphocyte homing. Immunity 15: 115-126.
25. + regulatory T cells maintain immune homeostasis in the skin. J. Exp. Med. 205: 1559-1565.
26. Harris, D. P., L. Haynes, P. C. Sayles, D. K. Duso, S. M. Eaton, N. M. Lepak, L. L. Johnson, S. L. Swain, and F. E. Lund. 2000. Reciprocal regulation of polarized cytokine production by effector B and T cells. Nat. Immunol. 1: 475-482.
27. Granucci, F., C. Vizzardelli, N. Pavelka, S. Feau, M. Persico, E. Virzi, M. Rescigno, G. Moro, and P. Ricciardi-Castagnoli. 2001. Inducible IL-2 production by dendritic cells revealed by global gene expression analysis. Nat. Immunol. 2: 882-888.
28. Schultz, M., S. H. Clarke, L. W. Arnold, R. B. Sartor, and S. L. Tonkonogy. 2001. Disrupted B-lymphocyte development and survival in interleukin-2-deficient mice. Immunology 104: 127-134.
29. Vosshenrich, C. A., T. Ranson, S. I. Samson, E. Corcuff, F. Colucci, E. E. Rosmaraki, and J. P. Di Santo. 2005. Roles for common cytokine receptor γ-chain-dependent cytokines in the generation, differentiation, and maturation of NK cell precursors and peripheral NK cells in vivo. J. Immunol. 174: 1213-1221.
30. Granucci, F., I. Zanoni, N. Pavelka, S. L. Van Dommelen, C. E. Andoniou, F. Belardelli, M. A. Degli Esposti, and P. Ricciardi-Castagnoli. 2004. A contribution of mouse dendritic cell-derived IL-2 for NK cell activation. J. Exp. Med. 200: 287-295.
31. Kündig, T. M., H. Schorle, M. F. Bachmann, H. Hengartner, R. M. Zinkernagel, and I. Horak. 1993. Immune responses in interleukin-2-deficient mice. Science 262: 1059-1061.
32. + T cell homeostasis. J. Immunol. 178: 1251-1255.
33. Sharma, R., A. C. Ju, J. T. Kung, S. M. Fu, and S. T. Ju. 2008. Rapid and selective expansion of nonclonotypic T cells in regulatory T cell-deficient, foreign antigen-specific TCR-transgenic scurfy mice: antigen-dependent expansion and TCR analysis. J. Immunol. 181: 6934-6941.
34. Early, S. B., E. Barekzi, J. Negri, K. Hise, L. Borish, and J. W. Steinke. 2007. Concordant modulation of cysteinyl leukotriene receptor expression by IL-4 and IFN-γ on peripheral immune cells. Am. J. Respir. Cell Mol. Biol. 36: 715-720.
35. H2 cytokine-induced up-regulation of cysteinyl leukotriene receptor messenger RNA in human monocytes. Ann. Allergy Asthma Immunol. 99: 340-347.
36. Trajkovic, V., M. J. Sweet, and D. Xu. 2004. T1/ST2: an IL-1 receptor-like modulator of immune responses. Cytokine Growth Factor Rev. 15: 87-95.
37. Löhning, M., A. Stroehmann, A. J. Coyle, J. L. Grogan, S. Lin, J. C. Gutierrez-Ramos, D. Levinson, A. Radbruch, and T. Kamradt. 1998. T1/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector function. Proc. Natl. Acad. Sci. USA 95: 6930-6935.
38. Townsend, M. J., P. G. Fallon, D. J. Matthews, H. E. Jolin, and A. N. McKenzie. 2000. T1/ST2-deficient mice demonstrate the importance of T1/ST2 in developing primary T helper cell type 2 responses. J. Exp. Med. 191: 1069-1076.
39. Hoshino, K., S. Kashiwamura, K. Kuribayashi, T. Kodama, T. Tsujimura, K. Nakanishi, T. Matsuyama, K. Takeda, and S. Akira. 1999. The absence of interleukin 1 receptor-related T1/ST2 does not affect T helper cell type 2 development and its effector function. J. Exp. Med. 190: 1541-1548.
40. Cote-Sierra, J., G. Foucras, L. Guo, L. Chiodetti, H. A. Young, J. Hu-Li, J. Zhu, and W. E. Paul. 2004. Interleukin 2 plays a central role in Th2 differentiation. Proc. Natl. Acad. Sci. USA 101: 3880-3885.
41. Vogtenhuber, C., C. Bucher, S. L. Highfill, L. K. Koch, E. Goren, A. Panoskaltsis-Mortari, P. A. Taylor, M. A. Farrar, and B. R. Blazar. 2010. Constitutively active Stat5b in CD4+ T cells inhibits graft-versus-host disease lethality associated with increased regulatory T-cell potency and decreased T effector cell responses. Blood 116: 466-474.
42. Schaller, M. A., L. E. Kallal, and N. W. Lukacs. 2008. A key role for CC chemokine receptor 1 in T-cell-mediated respiratory inflammation. Am. J. Pathol. 172: 386-394.
43. Wang, G., T. Savinko, H. Wolff, M. C. Dieu-Nosjean, L. Kemeny, B. Homey, A. I. Lauerma, and H. Alenius. 2007. Repeated epicutaneous exposures to ovalbumin progressively induce atopic dermatitis-like skin lesions in mice. Clin. Exp. Allergy 37: 151-161.
44. Capriotti, E., E. C. Vonderheid, C. J. Thoburn, E. C. Bright, and A. D. Hess. 2007. Chemokine receptor expression by leukemic T cells of cutaneous T-cell lymphoma: clinical and histopathological correlations. J. Invest. Dermatol. 127: 2882-2892.
45. Borregaard, J., L. Skov, L. Wang, N. Ting, C. Wang, L. A. Beck, J. Sonne, and A. Clucas. 2008. Evaluation of the effect of the specific CCR1 antagonist CP-481715 on the clinical and cellular responses observed following epicutaneous nickel challenge in human subjects. Contact Dermat. 59: 212-219.
46. Gladue, R. P., S. H. Cole,M. L. Roach, L. A. Tylaska, R. T. Nelson, R. M. Shepard, J. D. McNeish, K. T. Ogborne, and K. S. Neote. 2006. The human specific CCR1 antagonist CP-481,715 inhibits cell infiltration and inflammatory responses in human CCR1 transgenic mice. J. Immunol. 176: 3141-3148.
47. Penido, C., M. F. Costa, M. C. Souza, K. A. Costa, A. L. Candéa, C. F. Benjamim, and M. G. Henriques. 2008. Involvement of CC chemokines in γδ T lymphocyte trafficking during allergic inflammation: the role of CCL2/ CCR2 pathway. Int. Immunol. 20: 129-139.
48. Xia, M., and Z. Sui. 2009. Recent developments in CCR2 antagonists. Expert Opin. Ther. Pat. 19: 295-303.
49. Kallinich, T., J. M. Muche, S. Qin, W. Sterry, H. Audring, and R. A. Kroczek. 2003. Chemokine receptor expression on neoplastic and reactive T cells in the skin at different stages of mycosis fungoides. J. Invest. Dermatol. 121: 1045-1052.
50. Gombert, M., M. C. Dieu-Nosjean, F. Winterberg, E. Bünemann, R. C. Kubitza, L. Da Cunha, A. Haahtela, S. Lehtimäki, A. Müller, J. Rieker, et al. 2005. CCL1-CCR8 interactions: an axis mediating the recruitment of T cells and Langerhans-type dendritic cells to sites of atopic skin inflammation. J. Immunol. 174: 5082-5091.
51. Panina-Bordignon, P., A. Papi, M. Mariani, P. Di Lucia, G. Casoni, C. Bellettato, C. Buonsanti, D. Miotto, C. Mapp, A. Villa, et al. 2001. The C-C chemokine receptors CCR4 and CCR8 identify airway T cells of allergen-challenged atopic asthmatics. J. Clin. Invest. 107: 1357-1364.
52. Mikhak, Z., M. Fukui, A. Farsidjani, B. D. Medoff, A. M. Tager, and A. D. Luster. 2009. Contribution of CCR4 and CCR8 to antigen-specific TH2 cell trafficking in allergic pulmonary inflammation. J. Allergy Clin. Immunol. 123: 67-73.
53. Morgan, A. J., C. Guillen, F. A. Symon, S. S. Birring, J. J. Campbell, and A. J. Wardlaw. 2008. CXCR6 identifies a putative population of retained human lung T cells characterised by co-expression of activation markers. Immunobiology 213: 599-608.
54. Morgan, A. J., C. Guillen, F. A. Symon, T. T. Huynh, M. A. Berry, J. J. Entwisle, M. Briskin, I. D. Pavord, and A. J. Wardlaw. 2005. Expression of CXCR6 and its ligand CXCL16 in the lung in health and disease. Clin. Exp. Allergy 35: 1572-1580.
55. Scholz, F., A. Schulte, F. Adamski, C. Hundhausen, J. Mittag, A. Schwarz, M. L. Kruse, E. Proksch, and A. Ludwig. 2007. Constitutive expression and regulated release of the transmembrane chemokine CXCL16 in human and murine skin. J. Invest. Dermatol. 127: 1444-1455.
56. Wu, C., F. Ivars, P. Anderson, R. Hallmann, D. Vestweber, P. Nilsson, H. Robenek, K. Tryggvason, J. Song, E. Korpos, et al. 2009. Endothelial basement membrane laminin α5 selectively inhibits T lymphocyte extravasation into the brain. Nat. Med. 15: 519-527.
57. Ebeling, O., A. Duczmal, S. Aigner, C. Geiger, S. Schöllhammer, J. T. Kemshead, P. Möller, R. Schwartz-Albiez, and P. Altevogt. 1996. L1 adhesion molecule on human lymphocytes and monocytes: expression and involvement in binding to αvβ3 integrin. Eur. J. Immunol. 26: 2508-2516.
58. Reiss, Y., A. E. Proudfoot, C. A. Power, J. J. Campbell, and E. C. Butcher. 2001. CC chemokine receptor (CCR)4 and the CCR10 ligand cutaneous T cell-attracting chemokine (CTACK) in lymphocyte trafficking to inflamed skin. J. Exp. Med. 194: 1541-1547.
59. Alvarez, D., J. L. Arkinson, J. Sun, R. Fattouh, T. Walker, and M. Jordana. 2007. Th2 differentiation in distinct lymph nodes influences the site of mucosal Th2 immune-inflammatory responses. J. Immunol. 179: 3287-3296.
60. Lacotte, S., S. Brun, S. Muller, and H. Dumortier. 2009. CXCR3, inflammation, and autoimmune diseases. Ann. N. Y. Acad. Sci. 1173: 310-317.
61. Reutershan, J. 2006. CXCR2: the receptor to hit? Drug News Perspect. 19: 615-623.
62. Proost, P., A. Mortier, T. Loos, J. Vandercappellen, M. Gouwy, I. Ronsse, E. Schutyser, W. Put, M. Parmentier, S. Struyf, and J. Van Damme. 2007. Proteolytic processing of CXCL11 by CD13/aminopeptidase N impairs CXCR3 and CXCR7 binding and signaling and reduces lymphocyte and endothelial cell migration. Blood 110: 37-44.
63. Medoff, B. D., S. Y. Thomas, and A. D. Luster. 2008. T cell trafficking in allergic asthma: the ins and outs. Annu. Rev. Immunol. 26: 205-232.
64. Eri, R., J. R. Jonsson, N. Pandeya, D. M. Purdie, A. D. Clouston, N. Martin, D. Duffy, E. E. Powell, J. Fawcett, T. H. Florin, and G. L. Radford-Smith. 2004. CCR5-D32 mutation is strongly associated with primary sclerosing cholangitis. Genes Immun. 5: 444-450.
65. Tommasi, A. M., P. Fabris, I. Carderi, A. Baragiotta, V. Baldo, C. Venturi, M. T. Giordani, G. Tositti, and A. Floreani. 2006. Lack of higher frequency of the chemokine receptor 5-δ32/δ32 genotype in hepatitis C. J. Clin. Gastroenterol. 40: 440-443.
66. Park, H., Z. Li, X. O. Yang, S. H. Chang, R. Nurieva, Y. H. Wang, Y. Wang, L. Hood, Z. Zhu, Q. Tian, and C. Dong. 2005. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6: 1133-1141.
67. + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6: 1123-1132.
68. Larsson, K. 2008. Inflammatory markers in COPD. Clin. Respir. J. 2(Suppl. 1): 84-87.
69. Calabrese, C., M. Triggiani, G. Marone, and G. Mazzarella. 2000. Arachidonic acid metabolism in inflammatory cells of patients with bronchial asthma. Allergy 55(Suppl. 61): 27-30.
70. Avgerinou, G., A. V. Goules, P. G. Stavropoulos, and A. D. Katsambas. 2008. Atopic dermatitis: new immunologic aspects. Int. J. Dermatol. 47: 219-224.